Mynx Control Venous
Payments companies reported to CMS as associated with Mynx Control Venous. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mynx Control Venous, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mynx Control Venous
These are the largest totals companies reported as associated with Mynx Control Venous. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mohamed Elshazly | Lake Mary, FL | Clinical Cardiac Electrophysiology | $15,235.35 |
| Erin Murphy | Charlotte, NC | Vascular Surgery | $13,385.26 |
| Joseph Bumgarner | Raleigh, NC | Clinical Cardiac Electrophysiology | $12,750.00 |
| Kevin Makati | Lutz, FL | Cardiovascular Disease | $10,884.31 |
| Sanjaya Gupta | Kansas City, MO | Clinical Cardiac Electrophysiology | $5,817.82 |
| Bret Wiechmann | Gainesville, FL | Vascular & Interventional Radiology | $5,207.62 |
| Michael Stiefel | Atlanta, GA | Neurological Surgery | $4,509.30 |
| David Brabham | Amarillo, TX | Cardiovascular Disease | $3,600.00 |
| Peter Schneider | Honolulu, HI | Vascular Surgery | $3,407.10 |
| Foluso Fakorede | Cleveland, MS | Interventional Cardiology | $3,123.52 |
Prescribed Mynx Control Venous?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.